•
Mar 31, 2023

Akero Q1 2023 Earnings Report

Akero Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2023.

Key Takeaways

Akero Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2023.

EPS
-$0.55
Previous year: -$0.74
-25.7%
Cash and Equivalents
$258M
Previous year: $165M
+55.9%
Total Assets
$349M
Previous year: $170M
+105.3%

Akero

Akero